O'Connell Katie A, Thomas Jacob L, Murad Fadi, Zhou Guohai, Sonpavde Guru P, Mossanen Matthew, Clinton Timothy N, Ji-Xu Antonio, Spiess Philippe E, Rossi Anthony M, Schmults Chrysalyne D
Brigham & Women's/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
J Eur Acad Dermatol Venereol. 2025 Mar;39(3):576-585. doi: 10.1111/jdv.20093. Epub 2024 Jun 6.
Penile squamous cell carcinoma (PSCC) carries significant morbidity and mortality. Literature is limited regarding prognostic factors, especially prognostic factors for development of metastasis.
To identify independent prognostic factors associated with poor outcomes, defined as local recurrence (LR), metastasis and disease-specific death (DSD) in clinically node-negative PSCC undergoing local therapy.
Thirty-two-year Retrospective Multicenter Cohort Study of 265 patients with histologically diagnosed PSCC at three tertiary care centres. Predictive models based on patient or tumour characteristics were developed.
Local recurrence occurred in 56 patients, metastasis in 52 patients and DSD in 40 patients. In multivariable models, the following five factors were independent prognostic factors based on subhazard ratio (SHR): history of balanitis (LR SHR: 2.3; 95% CI 1.2-4.2), poor differentiation (metastasis SHR 1.9; 95% CI 1.0-3.6), invasion into the corpora (metastasis SHR: 3.0; 95% CI 1.5-5.8 and DSD SHR: 4.5; 95% CI 1.7-12.1), perineural invasion (PNI) (metastasis SHR: 2.8; 95% CI 1.4-5.5 and DSD SHR: 3.5; 95% CI, 1.6-7.8) and a history of phimosis (DSD SHR: 2.5; 95% CI 1.2-5.3). The 5-year cumulative incidence of metastasis was higher for tumours with PNI [cumulative incidence function (CIF) = 55%, 95% CI 38-75 vs. CIF 15%, 95% CI 11-22], corporal invasion (CIF: 35%, 95% CI 26-47 vs. 12%, 95% CI 7-19) and poorly differentiated tumours (CIF = 46%, 95% CI 31-64 vs. CIF 15%, 95% CI 11-22).
History of balanitis, history of phimosis, PNI, corporal invasion and poor differentiation are independent risk factors associated with poor outcomes. Since poor differentiation and PNI currently constitute only T1b disease, prognostic staging can likely be improved.
阴茎鳞状细胞癌(PSCC)具有较高的发病率和死亡率。关于预后因素的文献有限,尤其是转移发生的预后因素。
确定与不良结局相关的独立预后因素,不良结局定义为接受局部治疗的临床淋巴结阴性PSCC患者出现局部复发(LR)、转移和疾病特异性死亡(DSD)。
对三家三级医疗中心的265例经组织学诊断为PSCC的患者进行了为期32年的回顾性多中心队列研究。建立了基于患者或肿瘤特征的预测模型。
56例患者发生局部复发,52例患者发生转移,40例患者发生疾病特异性死亡。在多变量模型中,基于亚风险比(SHR),以下五个因素是独立的预后因素:龟头炎病史(LR SHR:2.3;95%CI 1.2 - 4.2)、低分化(转移SHR 1.9;95%CI 1.0 - 3.6)、侵犯海绵体(转移SHR:3.0;95%CI 1.5 - 5.8和DSD SHR:4.5;95%CI 1.7 - 12.1)、神经周围侵犯(PNI)(转移SHR:2.8;95%CI 1.4 - 5.5和DSD SHR:3.5;95%CI 1.6 - 7.8)和包茎病史(DSD SHR:2.5;95%CI 1.2 - 5.3)。PNI的肿瘤转移5年累积发病率更高[累积发病率函数(CIF)=55%,95%CI 38 - 75 vs. CIF 15%,95%CI 11 - 22],海绵体侵犯(CIF:35%,95%CI 26 - 47 vs. 12%,95%CI 7 - 19)和低分化肿瘤(CIF = 46%,95%CI 31 - 64 vs. CIF 15%,95%CI 11 - 22)。
龟头炎病史、包茎病史、PNI、海绵体侵犯和低分化是与不良结局相关的独立危险因素。由于目前低分化和PNI仅构成T1b疾病,预后分期可能会得到改善。